ALXN Forecast and Technical Stock Analysis
Sell candidate since 2019-09-11 Loss -2.37% PDF
Alexion Pharmaceuticals gained 0.62% in the last trading day ( Friday, 20th Sep 2019 ), rising from $105.67 to $106.32 , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the day the stock fluctuated 2.78% from a day low at $104.07 to a day high of $106.96. The price has been going up and down for this period, and there has been a 2.39% gain for the last 2 weeks. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 0.27 million more shares were traded than the day before. In total, 2.40 million shares bought and sold for approximately $255.09 million.
- 30 day high of the ALXN stock price was $125.52 and low was $94.93.
- 90 day high was $134.84 and low was $94.93.
- 52 week high for Alexion Pharmaceuticals - $141.86 and low - $92.56.
Alexion Pharmaceuticals lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -19.22% during the next 3 months and, with 90% probability hold a price between $72.33 and $92.75 at the end of this period.
A buy signal was issued from a pivot bottom point on Wednesday September 18, 2019, which indicates further gains until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. Alexion Pharmaceuticals holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $106.71 and $108.60. A break-up above any of these levels will issue buy signals.
Relative Strength Index (RSI)
RSImin/max Values: [ 25 - 75 ]
RSI14 is 59 and the stock is currently not being overbought or oversold
* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behaviour.
Support & Resistance
On the downside, the stock finds support just below today's level from accumulated volume at $100.76 and $97.53.
There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Alexion Pharmaceuticals finds support just below today's level at $100.76. If this is broken, then the next support from accumulated volume will be at $97.53 and $95.18.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $2.89 between high and low, or 2.78%. For the last week, the stock has had a daily average volatility of 3.08%.
Our recommended stop-loss: We hold a sell evaluation for this stock. No stop-loss set.
3.08 %Average volatility
Very Low Low Medium High Very High
|ALXN $106.32 ($0.65 0.62%)|
ALXN is up $0.65 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for ALXN based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the ALXN analysis is free »
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!